Abstract
Chemotherapy-induced alopecia (CIA) is a distressing adverse effect of anticancer drugs; however, there are currently no mechanisms to completely prevent CIA. In this study, we performed a clinical trial to examine whether sodium N-(dihydrolipoyl)-l-histidinate zinc complex (DHL-HisZnNa), an alpha-lipoic acid derivative, prevents CIA in patients with breast cancer. Between July 2014 and May 2015, we performed a multi-center, single arm, clinical trial involving 103 breast cancer patients who received adjuvant chemotherapy at three medical institutions in Japan. During chemotherapy, a lotion containing 1% DHL-HisZnNa was applied daily to the patients' scalps. The primary endpoint was the incidence of grade 2 alopecia; the secondary endpoints were the duration of grade 2 alopecia, alopecia-related symptoms, and drug-related adverse events. Alopecia was evaluated by three independent reviewers using head photographs taken from four angles. Safety analysis was performed for 101 patients who started the protocol therapy. After excluding one patient who experienced disease progression during treatment, 100 patients who received at least two courses of chemotherapy underwent efficacy analysis. All original 101 patients developed grade...Continue Reading
References
Oct 2, 1986·The New England Journal of Medicine·M Martin-JimenezB Sangro
Oct 1, 1985·Scandinavian Journal of Clinical and Laboratory Investigation·J BülowM Hansen
Jul 1, 1996·Journal of the American Academy of Dermatology·M DuvicL D Compton
Oct 9, 1998·The Journal of Investigative Dermatology·M B SchilliA Menrad
Aug 5, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Vladimir A Botchkarev
Aug 28, 2007·Psycho-oncology·Julie LemieuxLouise Provencher
Jun 19, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Floortje MolsWim P M Breed
Feb 19, 2009·The British Journal of Dermatology·C PrevezasP Reygagne
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Volker MoebusMichael Untch
May 3, 2011·Surgery Today·Satoshi HagiwaraTakayuki Noguchi
Dec 20, 2011·Journal of the American Academy of Dermatology·Susan Y ChonRashid M Rashid
Feb 9, 2012·Expert Opinion on Therapeutic Targets·Yohei KonoSeigo Kitano
May 11, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KlugerD Bessis
Jun 16, 2012·Archives of Dermatological Research·Francesco D'AgostiniSilvio De Flora
Apr 17, 2013·Oncology Reports·Takahiro HiratsukaSeigo Kitano
Sep 26, 2013·Acta Oncologica·Corina J van den HurkJan W Coebergh
Jan 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ChoS J Nam
Aug 2, 2014·International Journal of Cancer. Journal International Du Cancer·Hyoseung ShinSeung-Kwon Myung
Aug 6, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Wafaa Al-TameemiNikolaos T Georgopoulos
Oct 4, 2014·SpringerPlus·Kay Friedrichs, Martin H Carstensen
Feb 15, 2017·JAMA : the Journal of the American Medical Association·Julie NangiaMothaffar Rimawi
Mar 13, 2017·Journal of the American Academy of Dermatology·Athina FoniaCatherine M Stefanato
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KlugerD Bessis